Cimduo (lamivudine / tenofovir) is a combination HIV antiretroviral (ARV) medication. It contains two ARVs from the same class of medications and is not a full HIV regimen. When used in combination with dolutegravir (Tivicay), it's a first-choice treatment option.
Cimduo (lamivudine / tenofovir) is a combination tablet containing two ARVs from the same class of HIV medications. Lamivudine and tenofovir disoproxil fumarate are both nucleoside reverse transcriptase inhibitors (NRTIs). They insert themselves into the virus' DNA (genetic material) to stop the DNA-making process.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
*Side effects listed above are for Cimduo (lamivudine / tenofovir) taken in combination with efavirenz (Sustiva)
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report to your care team if they continue or are bothersome):
Cimduo and Temixys are two different brand names for the same combination of medications. Both tablets contain 300 mg of lamivudine and 300 mg of tenofovir disoproxil fumarate. They are made by two different manufacturers. Some insurance plans may only cover one of the two options.
Cimduo (lamivudine / tenofovir) is a combination tablet used for the treatment of HIV. It's an option for people who have never taken HIV ARVs in the past and for people who have experience with HIV ARVs, as long as they aren't allergic or resistant to the medications in Cimduo (lamivudine / tenofovir). It contains two different NRTIs, so it isn't a full HIV regimen and needs to be used with at least one other HIV ARV from another class.
Yes, in fact Cimduo (lamivudine / tenofovir) is one of the preferred NRTI combination tablets used during pregnancy. You're encouraged to enroll in the Antiretroviral Pregnancy Registry (APR) that monitors your health and your baby's health. If you're interested, ask your provider to help you enroll in the registry.
The CDC doesn't recommend people living with HIV to breastfeed, due to the risk of passing HIV to the breastfed infant.
Cimduo (lamivudine / tenofovir) is not approved for the treatment of hepatitis B in people who don't have HIV. Yet, it's a good option for people who have HIV and hepatitis B, since both ARVs work against the two viruses. For people who have HIV and hepatitis B, there's a chance your hepatitis B can worsen if you suddenly stop taking Cimduo (lamivudine / tenofovir). Don't stop taking your ARVs without talking to your provider.
Cimduo (lamivudine / tenofovir) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Don't stop taking Cimduo (lamivudine / tenofovir) without talking to your provider, especially if you have a history of hepatitis B. Doing so can make your hepatitis B get worse. If you have hepatitis B and your provider has instructed you to stop the medication or switch to a different antiviral medication, make sure you follow up with your provider and get your labs drawn regularly. This is how your provider will monitor your liver and hepatitis B infection. Let your provider know if you experience symptoms of hepatitis B infection, such as fever, tiredness, nausea, vomiting, dark urine, clay-colored stool, or yellowing of your skin or eyes.
Although rare, some people taking HIV medications similar to Cimduo (lamivudine / tenofovir) have experienced life-threatening blood acid problems and liver damage. Symptoms can include appetite loss, stomach pain with nausea or vomiting, muscle pain, fast and shallow breathing, extreme tiredness, and sudden weakness. Stop taking Cimduo (lamivudine / tenofovir) and go to the emergency room right away if this happens.
Some people taking Cimduo (lamivudine / tenofovir) have developed kidney problems. It can happen right after starting the medication or over time. Try to avoid other medications that can also harm the kidney, like high doses of NSAIDs (e.g., ibuprofen (Motrin, Advil), naproxen (Aleve). Make sure you get your blood tests drawn regularly so your provider can monitor your kidneys. Let your provider know if you have symptoms of kidney problems, such as swelling in your legs and feet, difficulty urinating, or confusion. Contact your provider right away if you experience bone or muscle pain, pain in the arms or legs, or fractures, as these can be signs of a specific kidney problem.
Some people might experience pancreatitis while taking Cimduo (lamivudine / tenofovir). Children who have taken NRTIs before, have a history of pancreatitis, or are at a high risk for pancreatitis should use Cimduo (lamivudine / tenofovir) with caution. Stop taking this medication and seek medical help right away if you or your child experiences stomach pain that spreads to the back, nausea, vomiting, fast heartbeat, or fever, as these could be signs of pancreatitis.
Cimduo (lamivudine / tenofovir) can lower your bone mineral density (BMD) and weaken your bones. This can potentially lead to osteoporosis and raise your risk of fractures (broken bones). Many people take calcium and vitamin D supplements to help prevent this. Your provider might order additional tests to check your bone density if you have a fracture or other risk factors for bone problems.
Cimduo (lamivudine / tenofovir) can cause harmful inflammation in your body as it starts to work. As the medication helps your body fight against HIV, your immune system starts to recover and becomes more active in fighting other infections that you may have. Recovery of your immune system is good, but the inflammation that can result from this can be dangerous. This is called immune reconstitution syndrome. Your healthcare provider might check for opportunistic infections (underlying infections that can happen with a weakened immune system) before you start Cimduo (lamivudine / tenofovir), especially if it's your first time taking an HIV ARV. You might need medications to help treat any infections that your provider detects. Call your provider if you experience fever, difficulty breathing, or sudden changes in your health after starting Cimduo (lamivudine / tenofovir).
Some people taking HIV ARVs have noticed changes in the way fat is stored in their body. This might show as more fat in the belly and upper back, and less fat in the face, arms, and legs. Scientists and healthcare providers don't really know why this happens.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 300mg/300mg | 30 tablets | $1,200.73 | $40.02 |
The recommended dose is 1 tablet by mouth once a day, with or without food. Each tablet contains 300 mg of lamivudine and 300 mg of tenofovir disoproxil fumarate (TDF).